Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/20/2008 | US20080286303 Mutant Hin47 protein with decreased protease activity, and a high molecular weight protein of a strain of non-typeable Haemophilus influenzae; may be combined with diphtheria or tetanus toxoids, pertussis antigens or non-virulent poliovirus; immunization; otitis media |
11/20/2008 | US20080286297 Chimeric Carrier Molecules for the Production of Mucosal Vaccines |
11/20/2008 | US20080286295 Use of recombinant antigens to determine the immune status of an animal |
11/20/2008 | US20080286293 Promiscuous pap cd4 t cell epitopes |
11/20/2008 | US20080286292 Molecular vaccine linking intercellular spreading protein to an antigen |
11/20/2008 | US20080286290 Anti-Cd14 Antibody Fusion Protein |
11/20/2008 | US20080286288 Vascular endothelial growth factor 2 |
11/20/2008 | US20080286285 Methods for Treating Vascular Disease |
11/20/2008 | US20080286284 Compositions of PSMA antibodies |
11/20/2008 | US20080286277 Monoclonal antibody comprising specificity determining residues for targeting tumor cells for destruction |
11/20/2008 | US20080286276 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
11/20/2008 | US20080286274 Vector for Efficient Selection and/or Maturation of an Antibody and Uses Thereof |
11/20/2008 | US20080286248 Hiv Vif Mutants |
11/20/2008 | US20080286247 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene |
11/20/2008 | US20080286198 Novel anti-IGF-IR antibodies and uses thereof |
11/20/2008 | US20080286161 Assembly; a cartridge that removably supports a substrate in a fixed position, and a reaction containment member having cavities that form chambers used to conduct biochemical processes directly over the substrate, thermal cycling of material contained inside the chamber |
11/20/2008 | DE4290124B4 Verfahren und Zusammensetzungen zur Expression von biologisch aktiven, eukaryontischen Cytochromen P450 in Bakterien Methods and compositions for the expression of biologically active eukaryotic cytochrome P450 in bacteria |
11/20/2008 | CA2723672A1 Gene expression and pain |
11/20/2008 | CA2716089A1 Method for increasing the resistance of a plant to endoparasitic nematodes |
11/20/2008 | CA2687715A1 Screening assay to identify correctors of protein trafficking defects |
11/20/2008 | CA2687304A1 Signaling peptides |
11/20/2008 | CA2687147A1 H5 subtype-specific binding proteins useful for h5 avian influenza diagnosis and surveillance |
11/20/2008 | CA2687115A1 Treatment and prevention of influenza |
11/20/2008 | CA2687001A1 Bone targeted alkaline phosphatase, kits and methods of use thereof |
11/20/2008 | CA2686908A1 Rna antagonist compounds for the modulation of her3 |
11/20/2008 | CA2686887A1 Pectate lyases with increased thermostability and/or enzymatic activity |
11/20/2008 | CA2686835A1 Novel herbicide resistance genes |
11/20/2008 | CA2686772A1 Vectors for multiple gene expression |
11/20/2008 | CA2686554A1 Optimization of colicin production |
11/20/2008 | CA2686201A1 Yield enhancement in plants by modulation of zmpkt |
11/20/2008 | CA2685994A1 Single-chain circular rna and method of producing the same |
11/20/2008 | CA2685879A1 Gene knockout mesophilic and thermophilic organisms, and methods of use thereof |
11/20/2008 | CA2685764A1 A method for sustainable transgene transcription |
11/20/2008 | CA2685551A1 Anti-tumor drug, medicament, composition, and use thereof |
11/20/2008 | CA2676149A1 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines |
11/20/2008 | CA2673535A1 Modified polymerases and attenuated viruses and methods of use thereof |
11/20/2008 | CA2673355A1 Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast |
11/20/2008 | CA2670315A1 Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof |
11/20/2008 | CA2670014A1 Production of anti-microbial peptides |
11/20/2008 | CA2668208A1 Hybrid immunoglobulins with moving parts |
11/20/2008 | CA2667297A1 Oligoribonucleotides and uses thereof |
11/20/2008 | CA2663249A1 Fluorescent proteins for monitoring intracellular superoxide production |
11/19/2008 | EP1992949A1 Microchip and soi substrate for manufacturing microchip |
11/19/2008 | EP1992706A2 Recombinase polymerase amplification |
11/19/2008 | EP1992704A1 Taqman mgb probe for detecting maternal inherited mitochondrial genetic deafness c1494t mutation and its usage |
11/19/2008 | EP1992703A1 Method for detection of mutant gene |
11/19/2008 | EP1992701A2 Kits and methods for assessing oxidative stress |
11/19/2008 | EP1992699A1 Method for increasing the resistance of a plant to endoparasitic nematodes |
11/19/2008 | EP1992698A1 METHOD FOR SYNTHESIS OF SUPPRESSOR tRNA, DNA CONSTRUCT, AND PRODUCTION OF PROTEIN HAVING NON-NATURAL AMINO ACID INTEGRATED THEREIN BY USING THE DNA CONSTRUCT |
11/19/2008 | EP1992697A1 Production of TNFR-Fc |
11/19/2008 | EP1992696A1 Circovirus sequences associated with porcine wasting disease (PWD) |
11/19/2008 | EP1992695A2 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
11/19/2008 | EP1992694A1 Anti-tumor drug, medicament, composition, and use thereof |
11/19/2008 | EP1992693A1 Absorption of nucleic acids to solid phases under low-salt conditions |
11/19/2008 | EP1992692A1 Immunoglobulin affinity ligand |
11/19/2008 | EP1992691A1 New TTV sequences for diagnosis, prevention and treatment of childhood leukaemia |
11/19/2008 | EP1992690A1 Method for detection of microorganism and kit for detection of microorganism |
11/19/2008 | EP1992689A1 Method for extraction of nucleic acid from biological material |
11/19/2008 | EP1992688A1 Method of constructing recombinant proteoliposome for diagnostic use |
11/19/2008 | EP1992687A2 Useful avian cell lines for producing useful substances |
11/19/2008 | EP1992686A1 OXA1P enhanced protein secretion |
11/19/2008 | EP1992682A1 Apparatus for real-time detection of nucleic acid amplification product |
11/19/2008 | EP1992644A1 Antibodies against CCR4 and its fragments |
11/19/2008 | EP1992643A2 Compositions and methods for the diagnosis and treatment of tumor |
11/19/2008 | EP1992642A1 Collagen fibrils carrying bioactive heterologous domains and their use in e.g. wound healing |
11/19/2008 | EP1992640A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
11/19/2008 | EP1992636A2 Process for correction of a disulfide misfold in Fc molecules |
11/19/2008 | EP1992635A1 Immunostimulatory sequence oligonucleotides and methods of using the same |
11/19/2008 | EP1992634A1 Oligonucleotide n3'- p5' thiophosphoramidates: their synthesis and use |
11/19/2008 | EP1992633A1 VEGI, an inhibitor of angiogenesis and tumor growth |
11/19/2008 | EP1992359A1 Neurotropic virus transport |
11/19/2008 | EP1992358A1 Aids vaccine based on replicative vaccinia virus vector |
11/19/2008 | EP1992221A1 Closterovirus-resistant plants |
11/19/2008 | EP1992220A1 Plant having reduced lignin and cellulose contents without reducing glucan content, method of producing the same and utilization thereof |
11/19/2008 | EP1992219A1 Plant having improved growth ability and disease resistance and method for production thereof |
11/19/2008 | EP1991710A2 Method for screening hiv drug sensitivity |
11/19/2008 | EP1991693A1 Method for differentiating between multiple sclerosis subtypes |
11/19/2008 | EP1991689A1 Process for the production of a fine chemical |
11/19/2008 | EP1991686A1 Adenovirus particles having a chimeric adenovirus spike protein, use thereof and methods for producing such particles |
11/19/2008 | EP1991685A2 Compositions and methods for increasing plant tolerance to high population density |
11/19/2008 | EP1991684A1 Method for producing polyunsaturated fatty acids |
11/19/2008 | EP1991683A1 Plants having increased yield and a method for making the same |
11/19/2008 | EP1991682A1 Plant metabolite exporter gene promoters |
11/19/2008 | EP1991681A1 Disease resistant plants |
11/19/2008 | EP1991680A2 System for the expression of orthogonal translation components in eubacterial host cells |
11/19/2008 | EP1991679A2 Human interferon-gamma (ifngamma) variants |
11/19/2008 | EP1991678A2 Compositions and methods for oligonucleotide formulations |
11/19/2008 | EP1991676A1 Method for mass production of primary metabolites, strain for mass production of primary metabolites, and method for preparation thereof |
11/19/2008 | EP1991675A1 End modification to prevent over-representation of fragments |
11/19/2008 | EP1991674A1 Methods and means for metabolic engineering and improved product formation by micro-organisms |
11/19/2008 | EP1991661A2 Non-lactose fermenting lactobacillus helveticus |
11/19/2008 | EP1991583A1 Thymic stromal lymphopoietin (tslp) antibodies and uses thereof |
11/19/2008 | EP1991580A2 Generation of heavy-chain only antibodies in transgenic animals |
11/19/2008 | EP1991578A2 Molecules and methods of using same for treating ccr5/ccr5 ligands associated diseases |
11/19/2008 | EP1991573A2 Peptides with properties of an allosteric antagonist selective for the alpha 1a adrenergic receptor and uses thereof |
11/19/2008 | EP1991571A2 Antiviral agents and vaccines against influenza |
11/19/2008 | EP1991570A1 Ammonia transporter gene and use thereof |
11/19/2008 | EP1991568A2 Genes for enhancing nitrogen utilization efficiency in crop plants |
11/19/2008 | EP1991567A2 Polynucleotide encoding a maize herbicide resistance gene and methods for use |
11/19/2008 | EP1991565A2 Shiga toxoid chimeric proteins |